Announcement 05/10/2007
Dr. Athanase Lavidas, Chairman and CEO, 3.378.583 shares amounting to 10.811.465,60 euros, Lavipharm Group Holdings SA, 2.576.588 shares, amounting to 8.245.081,60 euros, Mrs. Tania- Panagiota Vranopoulos, Counselor & Executive Member of the BoD, 27.279 shares amounting to 87.292,80 euros, Mr. Spyros Fotinos, Executive Member of the BoD, 54.600 shares amounting to 174.720,00 euros, Mrs. Loukia Lavidas, non- Executive Member of the BoD, 25.438 shares amounting to 81.401,60 euros, Mr. Evaggelos Athanasas, non- Executive Member of the BoD, 53.334 shares amounting to 170.688,80 euros, Mr. Christodoulos Maniatis, Group CFO, 21.401 shares amounting to 68.483,20 euros, Mrs. Eleni Markou, Group Director of Human Resources and Administrative Affairs, 1.900 shares amounting to 6.080,00 euros, Mr. Ioannis Alexiadis, Finance Manager, 1.570 shares amounting to 5.024,00 euros, Mr. Panagiotis Kousoulis, Group Plant Director, 2.276 shares amounting to 7.283,20 euros, Mr. Panagiotis Pavlou, Group Accounting Director, 300 shares amounting to 960,00 euros, Mr. Vasilis Vasilakopoulos, IT Manager, 6.250 shares amounting to 20.000,00 euros, Mrs. Eleni Moriati, Group Financial Controlling and Analysis Manager, 2.270 shares amounting to 7.264,00 euros, Mrs. Katerina Fragioudakis, Head of Corporate Communications, 700 shares amounting to 2.240,00 euros, Mr. Telemaque Lavidas, 55.017 shares amounting to 176.054,40 euros, Mrs. Elli- Maria Lavidas, 41.784 shares amounting to 133.708,80 euros and ATLANTIS 2000 S.A., 8.929 shares amounting to 28.572,80 euros.
The above mentioned shares purchased during the Company’s Share Capital Increase were available in the beneficiaries’ accounts on Tuesday, October 2nd, 2007.